BR005-036C

N/A

Report date: 2026/03/17 20:00:15
NME

Base Information

Drug NameBR005-036C
Drug Alias NameBR005-036CBR005036C
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCalcitonin gene-related peptide antagonists
TargetsCalcitonin gene-related peptide
Therapy Area/IndicationsMigraine without AuraMigraine with AuraMigraine Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesXiyuan Anjian Pharmaceutical (Shanghai) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesXiyuan Anjian Pharmaceutical (Shanghai) Co Ltd
Inactive CompaniesN/A
Active IndicationsMigraine without AuraMigraine with AuraMigraine Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A